電子ドラッグデリバリーシステムの世界市場:タイプ別、疾患別、地域別予測 2019-2026

LINEで送る

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Key Trends
1.3. Global & Segmental Market Estimates & Forecasts, 2016-2026 (USD Billion)
1.3.1. Electronic Drug Delivery Systems Market, by Type, 2016-2026 (USD Billion)
1.3.2. Electronic Drug Delivery Systems Market, by Indication, 2016-2026 (USD Billion)
1.3.3. Electronic Drug Delivery Systems Market, by Region, 2016-2026 (USD Billion)
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Electronic Drug Delivery Systems Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Industry Evolution
2.2.2. Scope of the Study
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Electronic Drug Delivery Systems Market Dynamics
3.1. See Saw Analysis
3.1.1. Market Drivers
3.1.2. Market Challenges
3.1.3. Market Opportunities
Chapter 4. Global Electronic Drug Delivery Systems Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Buyers
4.1.2. Bargaining Power of Suppliers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model
4.2. PEST Analysis
4.2.1. Political Scenario
4.2.2. Economic Scenario
4.2.3. Social Scenario
4.2.4. Technological Scenario
4.3. Key Buying Criteria (On Demand)
4.4. Regulatory Framework (On Demand)
4.5. Investment Vs Adoption Scenario (On Demand)
4.6. Analyst Recommendation & Conclusion
Chapter 5. Global Electronic Drug Delivery Systems Market, by Type
5.1. Market Snapshot
5.2. Market Performance – Potential Model
5.3. Electronic Drug Delivery Systems Market, Sub Segment Analysis
5.3.1. Electronic Wearable Infusion Pumps
5.3.1.1. Market estimates & forecasts, 2016-2026 (USD Billion)
5.3.1.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
5.3.2. Electronic Autoinjectors
5.3.2.1. Market estimates & forecasts, 2016-2026 (USD Billion)
5.3.2.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
5.3.3. Electronic Injection Pens
5.3.3.1. Market estimates & forecasts, 2016-2026 (USD Billion)
5.3.3.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
5.3.4. Electronic Inhalers
5.3.4.1. Market estimates & forecasts, 2016-2026 (USD Billion)
5.3.4.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
Chapter 6. Global Electronic Drug Delivery Systems Market, by Indication
6.1. Market Snapshot
6.2. Market Performance – Potential Model
6.3. Electronic Drug Delivery Systems Market, Sub Segment Analysis
6.3.1. Diabetes
6.3.1.1. Market estimates & forecasts, 2016-2026 (USD Billion)
6.3.1.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
6.3.2. Multiple Sclerosis
6.3.2.1. Market estimates & forecasts, 2016-2026 (USD Billion)
6.3.2.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
6.3.3. Cardiovascular Disease
6.3.3.1. Market estimates & forecasts, 2016-2026 (USD Billion)
6.3.3.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
6.3.4. Asthma & COPD
6.3.4.1. Market estimates & forecasts, 2016-2026 (USD Billion)
6.3.4.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
6.3.5. Other Indications
6.3.5.1. Market estimates & forecasts, 2016-2026 (USD Billion)
6.3.5.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
Chapter 7. Global Electronic Drug Delivery Systems Market, by Regional Analysis
7.1. Electronic Drug Delivery Systems Market, Regional Market Snapshot (2016-2026)
7.2. North America Electronic Drug Delivery Systems Market Snapshot
7.2.1. U.S.
7.2.1.1. Market estimates & forecasts, 2016-2026 (USD Billion)
7.2.1.2. Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
7.2.1.3. Indication breakdown estimates & forecasts, 2016-2026 (USD Billion)
7.2.2. Canada
7.2.2.1. Market estimates & forecasts, 2016-2026 (USD Billion)
7.2.2.2. Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
7.2.2.3. Indication breakdown estimates & forecasts, 2016-2026 (USD Billion)
7.3. Europe Electronic Drug Delivery Systems Market Snapshot
7.3.1. U.K.
7.3.1.1. Market estimates & forecasts, 2016-2026 (USD Billion)
7.3.1.2. Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
7.3.1.3. Indication breakdown estimates & forecasts, 2016-2026 (USD Billion)
7.3.2. Germany
7.3.2.1. Market estimates & forecasts, 2016-2026 (USD Billion)
7.3.2.2. Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
7.3.2.3. Indication breakdown estimates & forecasts, 2016-2026 (USD Billion)
7.3.3. Rest of Europe
7.3.3.1. Market estimates & forecasts, 2016-2026 (USD Billion)
7.3.3.2. Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
7.3.3.3. Indication breakdown estimates & forecasts, 2016-2026 (USD Billion)
7.4. Asia Electronic Drug Delivery Systems Market Snapshot
7.4.1. China
7.4.1.1. Market estimates & forecasts, 2016-2026 (USD Billion)
7.4.1.2. Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
7.4.1.3. Indication breakdown estimates & forecasts, 2016-2026 (USD Billion)
7.4.2. India
7.4.2.1. Market estimates & forecasts, 2016-2026 (USD Billion)
7.4.2.2. Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
7.4.2.3. Indication breakdown estimates & forecasts, 2016-2026 (USD Billion)
7.4.3. Japan
7.4.3.1. Market estimates & forecasts, 2016-2026 (USD Billion)
7.4.3.2. Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
7.4.3.3. Indication breakdown estimates & forecasts, 2016-2026 (USD Billion)
7.4.4. Rest of Asia Pacific
7.4.4.1. Market estimates & forecasts, 2016-2026 (USD Billion)
7.4.4.2. Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
7.4.4.3. Indication breakdown estimates & forecasts, 2016-2026 (USD Billion)
7.5. Latin America Electronic Drug Delivery Systems Market Snapshot
7.5.1. Brazil
7.5.1.1. Market estimates & forecasts, 2016-2026 (USD Billion)
7.5.1.2. Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
7.5.1.3. Indication breakdown estimates & forecasts, 2016-2026 (USD Billion)
7.5.2. Mexico
7.5.2.1. Market estimates & forecasts, 2016-2026 (USD Billion)
7.5.2.2. Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
7.5.2.3. Indication breakdown estimates & forecasts, 2016-2026 (USD Billion)
7.6. Rest of The World
7.6.1. Middle East and Africa
7.6.1.1. Market estimates & forecasts, 2016-2026 (USD Billion)
7.6.1.2. Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
7.6.1.3. Indication breakdown estimates & forecasts, 2016-2026 (USD Billion)
Chapter 8. Competitive Intelligence
8.1. Company Market Share (Subject to Data Availability)
8.2. Top Market Strategies
8.3. Company Profiles
8.3.1. Merck Group (Germany)
8.3.1.1. Overview
8.3.1.2. Financial (Subject to Data Availability)
8.3.1.3. Product Summary
8.3.1.4. Recent Developments
8.3.2. Insulet Corporation (US)
8.3.3. Bayer AG (Germany)
8.3.4. Medtronic PLC (Ireland)
8.3.5. Novo Nordisk (Denmark)
8.3.6. United Therapeutics Corporation (US)
8.3.7. AstraZeneca (UK)
8.3.8. Tandem Diabetes Care (US)
8.3.9. Amgen (US)
Chapter 9. Research Process
9.1. Research Process
9.1.1. Data Mining
9.1.2. Analysis
9.1.3. Market Estimation
9.1.4. Validation
9.1.5. Publishing
9.1.6. Research Assumption




※当サイトのレポート紹介カバレッジ
■産業:医療、IT、電子、自動車、産業機械、建設、消費財、食品、化学、材料、エネルギー、金融、サービスなど多様
■地域:世界市場、アジア市場、中国市場、欧州市場、北米市場、中南米市場、中東市場、アフリカ市場など全世界
■レポート種類:市場動向、規模、占有率、トレンド、将来展望、未来予測、業界分析、産業分析、企業分析、事業機会分析、戦略提言など多様